Boston Scientific Corporation vs Norfolk Southern Corporation — how do they compare? Boston Scientific Corporation trades at $51.05 (market cap $74.19B), while Norfolk Southern Corporation trades at $333.81 (market cap $75.15B). The key difference: Boston Scientific Corporation and Norfolk Southern Corporation are close in size by market cap, and Norfolk Southern Corporation pays a 1.61% dividend while Boston Scientific Corporation pays none. Which is the better fit depends on your goals.
| BSX | NSC | |
|---|---|---|
Market Cap | $74.19B | $75.15B |
Sector | Health | Technology |
52-Week High | $108.14 | $350.66 |
52-Week Low | $42.63 | $272.35 |
Enterprise Value | $86.27B | $90.70B |
Dividend Yield | — | 1.61% |
Trailing returns across standard periods
Latest headlines on both assets
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Read more on BSX →Norfolk Southern Corporation is a major North American railroad company operating one of the largest freight rail networks in the eastern United States. The company transports a diverse range of commodities, including coal, intermodal containers, and various industrial products. NSC is a critical link in the nation's supply chain, providing efficient, long-haul transportation services to and from ports and industrial centers.
Read more on NSC →